Marker | Minor Allele | Group* | Call rate | Genotype Frequency [%]§ | Allele Frequency [%] | |||||
---|---|---|---|---|---|---|---|---|---|---|
 |  |  |  | n | 0 | 1 | 2 |  | 95% CI | pub.** |
CYP1A1(VAL462ILE) | G | P | 91% | 217 | 93 | 7 | 0 | 3 | 3–4 | 2 [57] |
 |  | C |  | 212 | 92 | 8 | 0 | 4 | 3–4 |  |
GSTP1(A-193C) | G | P | 94% | 221 | 43 | 45 | 12 | 34 | 32–36 | 30 [58] |
 |  | C |  | 218 | 43 | 49 | 8 | 32 | 30–34 |  |
EPHX1(His113Tyr) | C | P | 96% | 233 | 55 | 38 | 7 | 26 | 25–28 | 32 [57] |
 |  | C |  | 219 | 49 | 43 | 8 | 29 | 28–31 |  |
EPHX1(Arg139His) | G | P | 86% | 191 | 68 | 29 | 4 | 18 | 17–20 | 22 [57] |
 |  | C |  | 208 | 69 | 27 | 3 | 17 | 16–18 |  |
NAT2(Thr114Ile) | C | P | 94% | 222 | 34 | 51 | 15 | 41 | 39–43 | 46 [57] |
 |  | C |  | 218 | 31 | 55 | 14 | 42 | 39–44 |  |
NAT2(Gln197Arg) | A | P | 95% | 229 | 50 | 44 | 7 | 28 | 27–30 | 29 [57] |
 |  | C |  | 218 | 50 | 41 | 10 | 30 | 28–32 |  |
XPD(Asp312Asn) | A | P | 92% | 221 | 39 | 45 | 15 | 38 | 36–40 | 33 [49] |
 |  | C |  | 209 | 37 | 45 | 18 | 40 | 38–42 |  |
XRCC1(Arg280His) | A | P | 94% | 232 | 91 | 9 | 1 | 5 | 5–6 | 3 [59] |
 |  | C |  | 211 | 90 | 10 | 0 | 5 | 5–6 |  |
XRCC1(Arg399Gln) | A | P | 86% | 197 | 43 | 44 | 13 | 35 | 33–38 | 38 [59] |
 |  | C |  | 204 | 43 | 45 | 12 | 34 | 32–37 |  |
GPX1(Pro200Leu) | T | P | 85% | 186 | 61 | 34 | 5 | 22 | 20–24 | 31 [60] |
 |  | C |  | 207 | 47 | 43 | 10 | 31 | 29–33 |  |
p53(Arg72Pro) §§ | C | P | 87% | 201 | 56 | 34 | 10 | 27 | 25–29 | 33 [61] |
 |  | C |  | 204 | 56 | 38 | 6 | 25 | 23–27 |  |